col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


244 Results       Page 1

 [1] 
Ovid: HemaSphere
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―19 Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study Tereza Faitová, Christian Brieghel, Frank Eriksson, Carsten U. Niemann
2 [GO] 2024―Mar―10 Clonal hematopoiesis and COVID-19 hospitalization in Danish adults Celia Burgos Sequeros, Morten Tulstrup, Sofie Bliddal, Karina Meden Sørensen, Ioanna Nissen, Omid Rezahosseini, et al. (+27)
3 [GO] 2023―Aug―25 PB2592: THERAPEUTIC PLASMA EXCHANGE THERAPY SUPPORT FOR COVID-19 WITH NEUROLOGICAL COMPLICATIONS: A CASE REPORT Xing Cui, Manya Yu
4 [GO] 2023―Aug―25 PB2588: PREDICTIVE MODEL OF IN-HOSPITAL CASE FATALITY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA DEVELOPING CORONAVIRUS INFECTION Yuri Polyakov, Elena Baryakh, Elena Misyurina, Eugenia Zhelnova, Konstantin Yatskov, Marat Mingalimov, et al. (+5)
5 [GO] 2023―Aug―24 PB2666: MAIN DISORDERS AND COAGULATION PARAMETERS IN PATIENTS WITH COVID-19 Valentyna Kubarova, Nadiia Goryainova, Svitlana Burnaeva, Bohdana Kuiavovych
6 [GO] 2023―Aug―24 PB2591: REAL WORLD DATA OF THE MANAGEMENT (TREATMENT AND PREVENTION OF COVID-19 DISEASE) IN PATIENTS WITH HEMATOLOGICAL DISEASES DURING THE PANDEMIC Aikaterini Mparmpouti, Kyranna Lafara, Konstantina Tsioni, Theodora Dimou, Christos Vettas, Evdokia Mandala
7 [GO] 2023―Aug―24 P1630: A 2022 CROSS-NATIONAL SURVEY OF PEOPLE LIVING WITH HAEMOPHILIA DURING THE COVID-19 PANDEMIC: VIEWS ON VACCINATION- AND INFECTION-RELATED RISKS Ana Boban, Atanas Banchev, Angelika Bátorová, Melen Brinza, Barbara Faganel Kotnik, Letitia Pintilie-Ancuta, Ester Zapotocka
8 [GO] 2023―Aug―24 P1621: INCIDENCE, RISK FACTORS AND MORTALITY ASSOCIATED WITH MAJOR BLEEDING EVENTS IN HOSPITALIZED COVID-19 PATIENTS, TERTIARY CENTER EXPERIENCE Marko Lucijanic, Ida Tjesic-Drinkovic, Nevenka Piskac Zivkovic, Frane Pastrovic, Zrinka Rob, Mersiha Bacevac, et al. (+8)
9 [GO] 2023―Aug―23 P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19. Federico Mario Aletti, Annalisa Ruggeri, Piera Angelillo, Sara Mastaglio, Federico Erbella, Diego Palumbo, et al. (+10)
10 [GO] 2023―Aug―23 PB2452: PREVALENCE AND SEVERITY OF COVID-19 IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS IN CHINA Hongye Gao, Jiali Wang, Xinhui Zheng, Yigeng Cao, Aiming Pang, Erlie Jiang
11 [GO] 2023―Aug―23 PB2575: HIGH INCIDENCE OF RESPIRATORY TRACT INFECTIONS FOLLOWING COVID-19 WAVES IN PATIENTS WITH PLASMA CELL DYSCRASIAS Francesca Farina, Sarah Marktel, Valeria Ferla, Daniela Clerici, Sannipoli Daniele, Tommaso Perini, et al. (+6)
12 [GO] 2023―Aug―23 PB2464: STRATIFICATION AND IMMUNOLOGIC ANALYSIS OF PATIENTS WITH SARS-COV-2 INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION Man Chen, Hui Wang
13 [GO] 2023―Aug―23 P1537: MORTALITY AND BURDEN OF POST-COVID-19 SYNDROME HAVE REDUCED WITH TIME ACROSS SARS-COV-2 VARIANTS IN HAEMATOLOGY PATIENTS John Willan, Gaurav Agarwal, Nicola Bienz
14 [GO] 2023―Aug―22 P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE Mohammad Ammad Ud Din, Nayeon Oh, Aliyah Baluch, Olga Klinkova, Rod Quilitz, Melissa Alsina, et al. (+18)
15 [GO] 2023―Aug―22 P1546: HEMATOLOGIC ADVERSE EVENTS AFTER COVID-19 VACCINATION IN THE PHILIPPINES: A NATIONAL DATABASE STUDY Flordeluna Mesina, Charles Eryll Sy, Sapinoso Frances Alexandra, Joy Ann De Castro, Preeti Prer Vaswani, Rizza Ann Oquendo, Mark Ryann Lirasan
16 [GO] 2023―Aug―17 P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL Sebastian Birndt, Jakob Hammersen, Konstanze Döhner, Philipp Reuken, Paul Sauerbrey, Felicitas La Rosée, et al. (+10)
17 [GO] 2023―Aug―17 PB1944: INDIVIDUALS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA SHOW IMPAIRED HUMORAL BUT NORMAL CELLULAR IMMUNE RESPONSES AFTER RECEIVING A COMPLETE VACCINATION SCHEDULE AGAINST SARS-COV-2 Clara Sánchez-Menéndez, Magdalena Corona, Alejandro Zurdo, Alicia Simón-Rueda, Elena Mateos, Mario Manzanares, et al. (+7)
18 [GO] 2023―Aug―10 PB2423: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIOR INFECTION CAUSED BY THE SARS-COV-2 (COVID-19) Aleksandr Siniaev, Marina Popova, Yuliya Rogacheva, Valeria Ianbukhtina, Egor Kulagin, Sergey Bondarenko, et al. (+2)
19 [GO] 2023―Aug―10 PB2564: COVID-19 AND FERRITIN Bohdana Kuiavovych, Nadiia Goryainova, Olga Basova, Valentyna Kubarova
20 [GO] 2023―Aug―10 PB2580: THE VALUE OF HEMATOLOGIC INFLAMMATION INDICES FOR COVID-19 PATIENTS Eleni Petridou, Effrosyni Evripioti, Athanasia Agorasti
21 [GO] 2023―Aug―10 P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS Marko Lucijanic, Petra Bistrovic, Ana Jordan, Iva Mihaljevic, Stela Bukvic, Stjepan Kovacevic, et al. (+4)
22 [GO] 2023―Aug―09 PB2326: OUTCOMES OF ANTI-CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B-CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019 (COVID-19): A REAL-WORLD STUDY FROM CHINA Guoai Su, Kai Hu, Xiaoyan Ke, Hui Shi, Peihao Zheng, Fan Yang, et al. (+8)
23 [GO] 2023―Aug―09 P1575: TIKSAGEVIMAB/TSILGAVIMAB: EXPERIENCE OF USE FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN ADULT PATIENTS WITH ONCOHEMATOLOGICAL DISEASES Daria Chebykina, Sergey Voloshin, Marina Zenina, Alexey Kuvshinov
24 [GO] 2023―Aug―09 P1591: IMPACT OF COVID-19 ON THE EVOLUTION OF PRE-EXISTING PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE OBSERVATIONAL STUDY Haixia Fu, Zhuo-Yu An, Qiu-Sha Huang, Ye-Jun Wu, Feitong Meng, Song Wang, et al. (+12)
25 [GO] 2023―Aug―09 P1651: IMPACT OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) AND MACROPHAGE ACTIVATION IN THE THROMBOTIC EVENTS IN COVID-19 PATIENTS Irene Serrano-Gonzalo, Bárbara Menéndez-Jandula, Isidro Arévalo-Vargas, Ester Franco-García, Carlos Lahoz, Paz Latre, et al. (+3)
26 [GO] 2023―Aug―09 P1557: A STUDY ON THE IMMUNOGENICITY OF COVID-19 VACCINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCY Flordeluna Mesina, Charles Eryll Sy
27 [GO] 2023―Aug―09 PB1746: EVOLUTION OF SARS-COV-2 INFECTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA Hamida Khémiri Guerbouj, Marwa Bahri, Amine Ben Moussa, Bizid Inaam, Manel Hamdoun Zahmoul, Hela Hannechi Rejeb, et al. (+4)
28 [GO] 2023―Aug―09 P1558: PROPHYLAXIS WITH TIXAGEVIMAB-CILGAVIMAB IN SINGLE-CENTER EXPERIENCE CAN REDUCE SEVERE COMPLICATIONS RELATED TO SARS-COV-2 INFECTION IN HEMATOLOGICAL PATIENTS Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Alessandra Romano, Amalia Stefania Figuera, Annalisa Chiarenza, et al. (+14)
29 [GO] 2023―Aug―09 P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY Sabine Haggenburg, Tom Reuvekamp, Quincy Hofsink, Cilia R. Pothast, Romy C. Dijkland, Kayleigh van Dijk, et al. (+12)
30 [GO] 2023―Aug―09 PB2427: THE RISK FACTORS ON THE SEVERITY OF SARS-COV2 OMICRON VARIANT INFECTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIEITC STEM CELL TRANSPLANTATION Zhihui LI, Qinlong Zheng, Lei Wang, Xianxuan Wang, Xiaopei Wen, Caiyan Zhang, et al. (+3)
31 [GO] 2023―Aug―09 PB2690: CURRENT STATUS AND FACTORS INFLUENCING FEAR OF COVID-19 IN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS: A CROSS-SECTIONAL STUDY Fucong Peng, Huijuan Zhang, Wenjun Xie, Guiying Liu, Qiuhui Zhang, Yuqiu Liu, et al. (+2)
32 [GO] 2023―Aug―09 PB1960: SARS-COV-2 OMICRON VARIANT INFECTION AND COVID-19 IN PERSONS WITH CHRONIC MYELOID LEUKAEMIA IN CHINA Fang Cheng, Weiming LI
33 [GO] 2023―Aug―09 P1342: THE IMPACT OF CLONAL HEMATOPOIESIS ON THE RISK OF SEVERE COVID-19 INFECTION Ryunosuke Saiki, Ho Namkoong, Qingbo Wang, Ryuya Edahiro, Kyuto Sonehara, Takanori Hasegawa, et al. (+13)
34 [GO] 2023―Aug―09 P1435: OUTCOMES OF COVID-19 INFECTION IN INDIVIDUALS WITH SICKLE CELL DISEASE OR SICKLE CELL TRAIT: A SYSTEMATIC REVIEW AND META-ANALYSIS Isabella Ferreira Michelon, Isabella Silveira Pinheiro, Isabela Lino Costa, Maysa Vilbert, Cecilia Fernandes Lorea, Mathias Castonguay, et al. (+2)
35 [GO] 2023―Aug―09 P1555: COVID-19 INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A SINGLE-CENTRE SURVEY DURING THE LATEST OMICRON WAVE IN CHINA Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, et al. (+17)
36 [GO] 2023―Aug―09 PB2615: HOW WILL COVID-19 RELATED SYMPTOMS AND PLATELET COUNTS CHANGE IN ITP PATIENTS AFTER COVID-19 INFECTION? Xiaoli Chen, Yao Quan, LI Wang, Hengrui Sun, Lei Gao, Peiyan Kong, et al. (+2)
37 [GO] 2023―Aug―09 P1461: INFLAMMATORY AND SENESCENCE-ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID-19 MRNA VACCINATION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS Veronica Bordoni, Maddalena Casale, Valeria Maria Pinto, Rita Carsetti, Barbara Gianesin, Maria Rita Gamberini, et al. (+15)
38 [GO] 2023―Aug―09 PB2671: AN INVESTIGATION INTO THE PREFERENCES OF PATIENTS REGARDING THE USE OF TELEMEDICINE STEMMING FROM THE COVID-19 PANDEMIC. Steve Kalloger, Cherie Bates, Amanda Watson, Lorna Warwick
39 [GO] 2023―Aug―09 PB2572: LYMPHOPENIA RATE; A FREE EPIDEMIOLOGICAL BIOMARKER FOR COVID-19 PANDEMIC Intissar Helali, Ikbel Ghachem, Malek Kaabar, Mootez Oueslati, Mohamed Yassine Kaabar, Asma Bachali
40 [GO] 2023―Aug―09 PB2705: PROFESSIONAL BURNOUT AMONG HEMATOLOGISTS AFTER THE OUTBREAK OF THE COVID-19 PANDEMIC AND ASSOCIATED FACTORS Olga Aleshina (Gavrilina), Tatiana Nikitina, Tatyana Ionova
41 [GO] 2023―Aug―09 P1550: HAEMATOLOGICAL PREDICTORS OF POOR OUTCOME AMONG COVID-19 PATIENTS ADMITTED TO AN INTENSIVE CARE UNIT OF A SOUTH AFRICAN TERTIARY HOSPITAL Zivanai Cuthbert Chapanduka, Ibtisam Abdullah, Brian Allwood, Coenraad Koegelenberg, Elvis Irusen, Usha Lalla, et al. (+2)
42 [GO] 2023―Aug―09 P1552: AN IMMUNE ATLAS OF THE DYSFUNCTIONAL CELLULAR AND ANTIBODY RESPONSE TO COVID-19 VACCINATION IN HEMATOLOGICAL PATIENTS WITH A MATURE B-CELL NEOPLASM Esperanza Martín-Sánchez, Camila Guerrero, Luis-Esteban Tamariz-Amador, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, et al. (+14)
43 [GO] 2023―Aug―09 P1487: CONCOMITANT USE OF SUTIMLIMAB AND COVID-19 VACCINES IN PATIENTS WITH COLD AGGLUTININ DISEASE FROM THE PHASE 3 CARDINAL AND CADENZA STUDIES Bruno Fattizzo, Alexander Röth, Catherine M Broome, Umer Khan, Frank Shafer, Matias Cordoba, Wilma Barcellini
44 [GO] 2023―Aug―09 P1300: CLINICAL CHARACTERISTICS AND OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS WITH CORONAVIRUS DISEASE 2019 CAUSED BY THE OMICRON VARIANT: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY Shuang Fan, Xiaodong Mo, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, et al. (+11)
45 [GO] 2023―Aug―09 P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE Luca Pezzullo, Valentina Giudice, Matteo D’addona, Danilo DE Novellis, Idalucia Ferrara, Raffaele Fontana, et al. (+6)
46 [GO] 2023―Aug―09 PB2534: SARS-COV-2 IMMUNIZATION AFTER VACCINES IN PATIENTS WITH HEMOGLOBINOPATHY: A SINGLE CENTER EXPERIENCE Andrea Duminuco, Anna Bulla, Rosamaria Rosso, Marina Romeo, Cambria Daniela, Enrico La Spina, et al. (+6)
47 [GO] 2023―Aug―09 PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY LI Jun, Ding Yao, Zhang Yong, Liu Zhanshu, Zailin Yang, Yang Zailiang, et al. (+7)
48 [GO] 2023―Aug―09 P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. Chiara Callegari, Martina Mutti, Alessandra Soravia, Pietro Lauzzana, Davide Lazzarotto, Maddalena Peghin, et al. (+3)
49 [GO] 2023―Aug―08 P1670: MICROPARTICAL-ASSOCIATED THROMBIN GENERATION IN PATIENTS AFTER MILD COVID-19 Olesia Matvienko, Natalia Silina, Olga Smirnova, Olga Golovina
50 [GO] 2023―Aug―08 P1576: NOVEL APPROACHES TO MANAGEMENT OF COVID-19 IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS Tatiana Chudnova, Elena Misyurina, Elena Baryakh, Tatyana Tolstykh, Yuri Polyakov, Olga Kochneva, et al. (+2)
51 [GO] 2023―Aug―08 P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, Yavuz M. Bilgin, Jens VAN Praet, Julio Dávila-Valls, et al. (+33)
52 [GO] 2023―Aug―08 P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY Jon Salmanton-García, Francesco Marchesi, Barbora Weinbergerová, Caterina Buquicchio, Natasa Čolović, Jens VAN Praet, et al. (+7)
53 [GO] 2023―Aug―08 P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS) Ilana Levy, Lior Rokach, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Tamar Tadmor
54 [GO] 2023―Aug―08 PB2146: CHARACTERISTICS AND OUTCOMES OF COVID-19 IN PATIENTS WITH PLASMA CELL DISORDERS DURING THE FIRST OMICRON WAVE IN BEIJING SINCE DECEMBER 2022: A RETROSPECTIVE STUDY AT A TERTIARY CENTER Qing He, Xuelin Dou, Yang Liu, Nan Peng, Lizong Gong, Lei Wen, Jin Lu
55 [GO] 2023―Aug―08 P1572: COVID-19 MORTALITY IN HIGH-RISK PATIENTS AFTER ALLO-HSCT AND CAR-T: IMPROVED OUTCOME THROUGH A PANDEMIC. Daniele Sannipoli, Gariazzo Camilla, Francesca Farina, Elisa Diral, Alessandro Bruno, Daniela Clerici, et al. (+10)
56 [GO] 2023―Aug―08 P1573: EVALUATION OF THE EFFICACY OF SARS-COV-2 VACCINATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING THE ERA OF THE COVID-19 PANDEMIC Евгений Куневич, Irina Martynkevich, Alexey Kuvshinov, Sergey Voloshin, Sergey Sidorkevich
57 [GO] 2023―Aug―08 PB2119: REDUCED OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS DURING THE COVID-19 PANDEMIC Alexander Luchinin, Elena Osipova, Natalia Minaeva
58 [GO] 2023―Aug―08 P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC Bart Scott, Mikkael Sekeres, Guillermo Garcia-Manero, David Grinblatt, Irene Degutis, Pavel Kiselev, et al. (+4)
59 [GO] 2023―Aug―08 PB2295: TITLE OF MANUSCRIPT: ESTABLISHING A TRANSNATIONAL HAEMATO-ONCOLOGY CANCER MULTIDISCIPLINARY TEAM DURING THE COVID-19 PANDEMIC IN A RESOURCE LIMITED SETTING Mohammad Aminul Islam, Amin Lutful Kabir, Zahed Khan, Mahbubur Rahman, Mohammad Abdul Aziz, Rumana Rashid, et al. (+8)
60 [GO] 2023―Aug―08 PB2288: INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN’S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY Yotam Bronstein, Eugene Feigin, Irit Avivi, Erel Joffe, Chava Perry
61 [GO] 2023―Aug―08 S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY Jon Salmanton-García, Francesco Marchesi, Maria Gomes Da Silva, Francesca Farina, Julio Dávila-Valls, Yavuz M. Bilgin, et al. (+67)
62 [GO] 2023―Aug―08 P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh
63 [GO] 2023―Aug―08 P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY Yeong Jer Lim, Victoria Ward, Liam Farrell, Dean Naisbitt, Anthony Brown, Eloise Phillips, et al. (+16)
64 [GO] 2023―Aug―08 P1661: THROMBOSIS AND BLEEDING IN CANCER PATIENTS WITH COVID-19: A DIFFICULT BALANCE Abdulrahman Al Raizah, Naveed Qureshi, Zied Aljubour, Afnan Alnajjar, Anas Alhason, Abdullah S. Al Saleh, et al. (+3)
65 [GO] 2023―Aug―08 PB1969: PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA Feiyang Qi, Mei Bao, Xiaoshuai Zhang, Shasha Zhao, Wenwen LI, Chenglei Wang, Qian Jiang
66 [GO] 2023―Aug―08 PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 Laura Perez, Miriam Solera, Magdalena Corona, Montserrat Torres, Guiomar Casado, Clara Sánchez-Menéndez, et al. (+7)
67 [GO] 2023―Aug―08 PB1976: SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION. Ivan Civettini, Laura Antolinni, Filippo Achille Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti-Passerini
68 [GO] 2023―Aug―08 P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN Huai-Chueh Gem Wu, Ling-Jung Chiu, Tung-Liang Lin, Yuen-Chin Ong, Ming-Chung Kuo, Yen-Min Huang, et al. (+7)
69 [GO] 2023―Aug―08 PB2070: IMMUNE RESPONSES AFTER SARS-COV-2 MRNA-VACCINATION AND INFECTION AT SINGLE CELL RESOLUTION IN PATIENTS WITH MULTIPLE MYELOMA Julius C. Enssle, Julia Campe, Alina Moter, Isabel Voit, Alec Gessner, Ika Weija Yu, et al. (+15)
70 [GO] 2023―Aug―08 P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL Alessandro Campanella, Antonella Capasso, Caterina Taccetti, Silvia Heltai, Elisa Albi, Yair Herishanu, et al. (+35)
71 [GO] 2023―Aug―08 P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT Nil Albiol, Elionor Lynton-Pons, Olga Aso, Esther Moga, Lucía Gómez-Pérez, Jose Alejandre-Santiago, et al. (+9)
72 [GO] 2023―Aug―08 PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS - A REAL-WORLD STUDY Ana Carolina Toreli, Marisol Miranda Galvis, Marcelo Addas Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Da Silva Santos Duarte, et al. (+12)
73 [GO] 2023―Aug―08 P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE Luca Pezzullo, Valentina Giudice, Matteo D’addona, Maria Teresa Buonanno, Danilo DE Novellis, Idalucia Ferrara, et al. (+7)
74 [GO] 2023―Jun―05 SARS-CoV-2 Infection in Patients With Waldenström’s Macroglobulinemia: A Multicenter International Cohort Study Irene Defrancesco, Virginia Valeria Ferretti, Pierre Morel, Charalampia Kyriakou, Efstathios Kastritis, Ibrahim Tohidi-Esfahani, et al. (+21)
75 [GO] 2023―May―11 P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC P. Musto, J. Salmanton-García, N. Sgherza, R. Bergantim, F. Farina, A. Glenthøj, et al. (+8)
76 [GO] 2023―May―11 P54 ORAL ANTIVIRALS RITONAVIR-NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID-19; A SINGLE-CENTER, PROSPECTIVE STUDY V. Spiliopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, M. Gavriatopoulou, F. Theodorakakou, D. Fotiou, et al. (+7)
77 [GO] 2023―May―11 P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA A. Duminuco, A. Romano, D. Leotta, E. La Spina, D. Cambria, A. Bulla, et al. (+6)
78 [GO] 2023―May―11 P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA I. Ntanasis-Stathopoulos, M. Gavriatopoulou, E. Eleutherakis-Papaiakovou, P. Malandrakis, V. Spiliopoulou, R.E. Syrigou, et al. (+7)
79 [GO] 2023―May―11 P64 A CASE OF COVID-19 PNEUMONIA AFTER CAR T-CELL THERAPY IN A PATIENT AFFECTED BY RELAPSED/REFRACTORY MULTIPLE MYELOMA C. Ielo, F. Fazio, S. Rocchi, I. Rizzello, E. Zamagni, MT Petrucci
80 [GO] 2023―May―11 P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT O. Annibali, Fazio F, Di Cecca M, Liberatore C, Pisani F, De Padua L, et al. (+10)
81 [GO] 2023―May―10 P63 BREAKTHROUGH COVID-19 IN FULL VACCINATED PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE OF 54 PATIENTS N. Sgherza, P. Curci, R. Rizzi, A. Perfetto, O. Battisti, N. Pizzileo, et al. (+2)
82 [GO] 2023―Apr―12 5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT -THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER M.V. Maria Vousvouki, A.T. Aikaterini Teli, A.A. Alkistis Adramerina, L.T. Labib Tarazi, M.E. Marina Economou
83 [GO] 2023―Apr―11 5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE J.E.M. Maran, M.P.D. Perdibon, I.B.D. Baido, M.N.G. Nkongne Gyslene, F.C.N. Canonici, V.M.N. Munaretto, et al. (+4)
84 [GO] 2023―Apr―11 5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA M.K.D. Dewi, L.D.R. Rahmartani, S.D.I. Iskandar, A.M.P. Pratanata, G.I. Ilmana, T.T.S. Sari, et al. (+2)
85 [GO] 2023―Apr―11 5574716 PROBLEMS AND STRATEGIES OF BLOOD TRANSFUSION IN THALASSEMIA DURING COVID-19 PANDEMIC IN INDONESIA L.D.R. Rahmartani, A.M. Pranata, S.D. Iskandar, T.T. Sari, P.A. Wahidiyat
86 [GO] 2023―Apr―11 5616412 SOCIAL DETERMINANTS OF HEALTH AND THEIR IMPACT ON FAMILIES OF CHILDREN WITH SICKLE CELL DISEASE DURING COVID-19 PANDEMIC S.L.M. Margulies, L.T. Thaniel, S.B. Speller-Brown, B.M. Martin, O.M. Martin, S.H. Harvey, et al. (+5)
87 [GO] 2023―Apr―11 5613043 THE EVOLUTION OF THE COVID-19 PANDEMIC IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: FROM ALPHA TO OMICRON O.Y. Martin, S. Margulies, B. Speller-Brown, S. Majumdar, D.S. Darbari, A.D. Campbell
88 [GO] 2023―Jan―26 COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel Naama Yekutiel, Gabriel Chodick, Lilac Tene, Yotam Bronstein, Moshe Grunspan, Noa Rivlin, et al. (+5)
89 [GO] 2023―Jan―23 SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance Nicola Sgherza, Daniela Di Gennaro, Paola Curci, Rita Rizzi, Daniela Roccotelli, Maria Croce, et al. (+12)
90 [GO] 2022―Dec―21 COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia Mazyar Shadman, Catherine Liu, Katherine Eakle, Hwai J. Hiew, Juliana M.L. Biondo, Paolo Ghia, Anthony R. Mato
91 [GO] 2022―Dec―08 Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, Yavuz M. Bilgin, Jens van Praet, Julio Dávila-Valls, et al. (+33)
92 [GO] 2022―Nov―15 Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases Davor Galusic, Sandra Basic-Kinda, Andela Pijuk, Vibor Milunovic, Barbara Dreta, Neven Franjic, et al. (+6)
93 [GO] 2022―Oct―10 P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi Chiara Rusconi, Benedetta Puccini, Carlo Visco, Francesca Ricci, Alessandro Re, Vittorio R. Zilioli, et al. (+7)
94 [GO] 2022―Sep―22 COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, et al. (+3)
95 [GO] 2022―Aug―23 Ferritin Increase in Hemochromatosis Subjects After Discontinuing Their Regular Maintenance Treatment: A Longitudinal Analysis Performed During the COVID-19 Imposed Hospital Lockdown Maria P. Coutinho, Maria José Teles, Graça Melo, Marta Lopes, Delfim Duarte, Tiago L. Duarte, et al. (+4)
96 [GO] 2022―Aug―15 P-041: DEATH ASSOCIATED WITH DELTA VARIANT COVID-19 AMONG SICKLE CELL DISEASE ADULT PATIENTS DURING THE 2021 4TH WAVE IN GUADELOUPE BERNIT E., TARER V., HARDY-DESSOURCES M., TRESSIÈRES B., DOUMDO L., PETRAS E., et al. (+2)
97 [GO] 2022―Aug―15 P-067: PROFILE OF INDIVIDUALS WITH SICKLE CELL DISEASE TESTED FOR COVID-19 BY POLYMERASE CHAIN REACTION IN A TERTIARY PEDIATRIC EMERGENCY HOSPITAL CELA M., FLOR-PARK M.
98 [GO] 2022―Aug―02 Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, Panagiotis Malandrakis, Aimilia D. Sklirou, Evangelos Eleutherakis-Papaiakovou, et al. (+10)
99 [GO] 2022―Aug―02 A Journey Into the Unknown: PhD Students in a European Training Network on Age-related Changes in Hematopoiesis Conduct Their Project During a Global Pandemic Christina Pitsillidou, Sandra Alonso-Rubido, Andrea Ávila-Ávila, Mari Carmen Romero-Mulero, Agata Labedz, Athanasios Oikonomou, et al. (+12)
100 [GO] 2022―Jun―30 P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID-19 T. Barbui, A. Carobbio, A. Masciulli, A. Iurlo, M. A. Sobas, E. M. Elli, et al. (+48)
101 [GO] 2022―Jun―30 P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC. T. Tolstykh, E. Baryakh, D. Ivanova, T. Chudnova, M. Misyurina, E. Medvedovskaya, et al. (+3)
102 [GO] 2022―Jun―30 P1580: MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS DURING THE COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE V. Filipponi, G. Palumbo, M. Ribersani, M. L. Moleti, A. Angi, M. C. Molinari, et al. (+2)
103 [GO] 2022―Jun―30 P807: APLASTIC ANEMIA FOLLOWING THE SARS-COV-2 VACCINE R. Babakhanlou, T. Kadia, K. Chien, P. Thompson
104 [GO] 2022―Jun―25 PB2253: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AS A PREDICTOR OF SEVERE COVID-19 ON ADMISSION M. Ababou, M. Meziane, C. Chouikh, M. Ababou, J. Laoutid, K. Doghmi
105 [GO] 2022―Jun―24 PB2217: SICKLE CELL DISEASE IS A RISK FACTOR FOR THE PROGRESSION AND PROGNOSIS OF COVID-19 V. Goyal, A. Singh, Y. Memon, N. Thakre, P. Sahu, R. Goyal
106 [GO] 2022―Jun―24 P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19. D. Ivanova, E. Baryakh, T. Tolstykh, T. Chudnova, Y. Polyakov, O. Kochneva, et al. (+3)
107 [GO] 2022―Jun―24 P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19 T. Chudnova, E. Baryakh, Y. Polyakov, T. Tolstykh, O. Kochneva, D. Ivanova, et al. (+5)
108 [GO] 2022―Jun―24 P1601: THE ASSESSMENT OF PREDICTIVE ROLE OF PROTEIN C AND S FOR CRITICAL FORM OF COVID-19 V. Popov, M. Andreescu, O. Patrinoiu, M. Popescu, M. Omer, F. Mihai, et al. (+9)
109 [GO] 2022―Jun―24 P1607: EPICOVIDEHA KIDS: A READY TO USE PLATFORM FOR EPIDEMIOLOGICAL STUDIES IN PEDIATRIC HEMATOLOGICAL PATIENTS WITH COVID-19 J. Salmanton-García, A. Busca, O. A. Cornely, M. Hoenigl, N. Klimko, P. Koehler, et al. (+6)
110 [GO] 2022―Jun―24 P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19 D. Blickstein, M. Izak, T. Filipovich- Rimon, O. Garach- Jehoshua, N. Rahimi- Levene, E. Shinar, et al. (+2)
111 [GO] 2022―Jun―24 P1673: THROMBOTIC COMPLICATIONS IN MERS-COV COMPARED TO COVID-19 A. Al Raizah, M. Alzahrani, A. Hejazi, M. Almegren, T. Alshuaibi, A. Alaskar
112 [GO] 2022―Jun―24 P1693: THROMBOMODULIN RESISTANCE: A NEW PROTHROMBOTIC PATHWAY IN COVID-19 A. Montaño, A. Marco, F. J. López Jaime, I. Fernández Bello, I. Márquez Gómez, J. M. Reguera Iglesias, et al. (+2)
113 [GO] 2022―Jun―24 P1637: RISKS FOR A PLATELET COUNT DROP: COVID-19 & ITP DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION (PDSA) PATIENT REGISTRY J. DiRaimo, C. Kruse, A. Kruse, M. Lambert, J. B. Bussel
114 [GO] 2022―Jun―24 P1618: CLINICAL OUTCOME OF COVID-19 CONVALESCENT PLASMA TRANSFUSION IN CHRONIC KIDNEY DISEASE PATIENTS ON RENAL REPLACEMENT THERAPY WITH SEVERE TO CRITICAL COVID-19 DISEASE J. Ahorro
115 [GO] 2022―Jun―24 PB1900: COVID-19 IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS S.-M. Galdean, R. Arbore, R. Ababei, D. Dragancea, R. A. Tomai, A. Trifa, et al. (+2)
116 [GO] 2022―Jun―24 PB2282: HERPESVIRUSES REPLICATION DURING COVID-19 IN NON-HODGKIN’S LYMPHOMA PATIENTS. K. Sychevskaya, S. Kravchenko, D. Tikhomirov, A. Korneeva, A. Abdulpatahov, R. Abdurashidova, et al. (+5)
117 [GO] 2022―Jun―24 PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES E. Zotina, E. Zhelnova, E. Karimova, E. Grishina, E. Paramonova, D. Gagloeva, et al. (+2)
118 [GO] 2022―Jun―24 P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION Y. Polyakov, K. Kaluzhskaya, E. Baryakh, E. Gemdzhian, E. Misyurina, E. Zhelnova, et al. (+6)
119 [GO] 2022―Jun―24 P1600: ANTIGENS OF THE DUFFY BLOOD GROUP SYSTEM AND RISK OF COVID-19 INFECTION E. Poponina, E. Butina, A. Yovdiy, N. Minaeva
120 [GO] 2022―Jun―24 P1615: AN ANALYSIS ACROSS ABO BLOOD GROUPS IN PATIENTS WITH COVID-19 INFECTION AND CORRELATION WITH HAEMATOLOGICAL BIOMARKERS, A SINGLE CENTRE STUDY H. Shokr, M. Marwah, S. Marwah, F. Wandroo
121 [GO] 2022―Jun―24 P1507: CLINICAL PROFILE OF COVID-19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS-COV-2 IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSAEMIA-THE EXPERIENCE OF A GREEK CENTER P. Delaporta, E. Terpos, E. E. Solomou, S. Gumeni, M.-I. Chatzielefteriou, K. Toutoudaki, et al. (+7)
122 [GO] 2022―Jun―24 P1594: LACTATE DEHYDROGENASE / ALBUMIN TO-UREA RATIO, A NEW PROGNOSTIC MARKER FOR THE PREDICTION OF COVID-19 INFECTION ASSOCIATED CLINICAL COMPLICATIONS. H. Shokr, M. Marwah, H. Siddiqi, F. Wandroo, S. Marwah
123 [GO] 2022―Jun―24 PB2259: MONOCYTE’S INVOLVEMENT IN INFLAMMATORY RESPONSE IN COVID-19 INFECTION IN CHRONIC RENAL DISEASE V. Bumbea, H. Bumbea, L. Ardelean, L. Radulescu, L. Damian, I. Dumitru, et al. (+4)
124 [GO] 2022―Jun―24 PB2280: COVID-19 INFECTION IN PATIENTS WITH ACUTE LEUKEMIA M. Shapetska, I. Iskrov, I. Stoma
125 [GO] 2022―Jun―24 PB2265: OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH B AND PLASMA CELL MALIGNANCIES DURING THE THIRD WAVE IN ARGENTINA: A SINGLE CENTER EXPERIENCE O. Gelo, L. Korin, L. Ayala, S. Cranco, E. Babuin, A. Vitriu, et al. (+13)
126 [GO] 2022―Jun―24 PB2220: MORTALITY IN PATIENTS WITH HEMOGLOBINOPATHIES AND (SARS-COV-2) COVID-19 INFECTION: SAUDI ARABIA EXPERIENCE H. Ezzat, O. Kashari, D. Alissa, R. Almasuood, A. Al-jedai
127 [GO] 2022―Jun―24 PB1908: COVID-19 INSIGHTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DIAGNOSIS AND TREATMENT V. Musteata
128 [GO] 2022―Jun―24 PB2236: HUMORAL RESPONSE TO SARS-COV-2 VACCINATION WITH BNT162B2 COVID-19 MRNA IN PATIENTS WITH HAEMOGLOBINOPATHIES I. Giatagantzidou, D. Pantelidou, D. Papadopoulou, E. Sidiropoulou, S. Dionysopoulou, P. Zebekakis, L. Skoura
129 [GO] 2022―Jun―24 P1610: IMPACT OF COVID-19 ON PATIENTS TREATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION - A RETROSPECTIVE COHORT STUDY T. Silfverberg, H. Cherif, K. Carlson, B. Wahlin
130 [GO] 2022―Jun―24 PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY L. Hariharan, M. Champion-Homfray, E. Hassan
131 [GO] 2022―Jun―24 PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC L. Schaff, M. Lobbous, D. Carlow, L. DeAngelis, L. B. Nabors, C. Grommes
132 [GO] 2022―Jun―24 P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC X. Cai, X.-H. Zhang
133 [GO] 2022―Jun―24 P1729: COMPARING THE PSYCHOSOCIAL IMPACTS OF THE COVID-19 PANDEMIC BETWEEN HAEMATOLOGICAL CANCER AND MYELOMA PATIENTS: FINDINGS FROM AN ONLINE SURVEY S. J. Quinn, L. Anderson, L. Lohfeld, C. McShane
134 [GO] 2022―Jun―24 PB2224: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS) H. Ezzat, A. Al Zayed, H. Al Saeed, M. AlDarwish, M. Albagshi, H. Malhan, et al. (+10)
135 [GO] 2022―Jun―24 PB2083: STUDY CONDUCT AND PATIENT SAFETY DURING THE COVID-19 PANDEMIC: OBSERVATIONS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA FROM THE GAZELLE TRIAL OF OBINUTUZUMAB SHORT DURATION INFUSION M. A. Canales, T. A. Buchholz, T. Ishikawa, L. M. Fogliatto, J. Bortolini, F. J. Capote Huelva, et al. (+8)
136 [GO] 2022―Jun―24 P1720: HOW TO IMPROVE THE TIME IN THERAPEUTIC RANGE (TTR) OF ANTICOAGULATED CHILDREN DURING THE COVID-19 PANDEMIC: TELECONTROL VERSUS TRADITIONAL HOSPITAL CONTROL R. MARTOS MARTÍNEZ, L. BERMEJO MARTÍNEZ, D. CORNEJO CORRALES, M. YUSTE PLATERO, E. GONZALEZ ARIAS, P. BELTRÁN ALVAREZ, et al. (+5)
137 [GO] 2022―Jun―24 P1690: NEUTROPHIL EXTRACELLULAR TRAP (NET) LEVELS IN COVID-19 PATIENTS L. López De Frutos, I. Serrano-Gonzalo, I. Arevalo-Vargas, B. Menéndez-Jandula, E. Franco-García, C. Lahoz, et al. (+3)
138 [GO] 2022―Jun―24 P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS M. Lucijanic, I. Jurin, M. Sedinic, E. Soric, A. Sabljic, I. Hadzibegovic, et al. (+2)
139 [GO] 2022―Jun―24 P1683: PERSISTENT HYPERCOAGULABILITY, ENDOTHELIOPATHY AND INFLAMMATION IN COVID-19 PATIENTS APPROXIMATING 1 YEAR AFTER RECOVERY. B. E. Fan, S. W. Wong, C. L. L. Sum, G. H. Lim, B. P. Leung, R. Dalan, et al. (+7)
140 [GO] 2022―Jun―24 P1687: THROMBOEMBOLISM IN COVID-19 PATIENTS ON ECMO C. Jones, K. Chen, G. Cheng, V. Narendran
141 [GO] 2022―Jun―24 PB2303: THROMBOCYTOPENIA IN COVID-19 PATIENTS ON ECMO SUPPORT C. Jones, K. Chen, V. Narendran
142 [GO] 2022―Jun―24 P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY M. Lucijanic, E. Soric, M. Sedinic, A. Sabljic, S. Tomasinec, A. Pasaric, et al. (+10)
143 [GO] 2022―Jun―24 PB2296: THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN COVID-19 PATIENTS: A MONOCENTRIC STUDY W. Boufrikha, R. Mezriqui, N. Slama, S. Chouchene, S. Abidi, Z. Mlayah, et al. (+2)
144 [GO] 2022―Jun―24 PB2281: HOW TO AVOID FALSE-NEGATIVE AND FALSE-POSITIVE COVID-19 PCR TESTING I. Fevraleva, O. Glinshchikova, A. Sudarikov
145 [GO] 2022―Jun―24 PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES L. I. Pinczes, F. Magyari, E. Páyer, K. Farkas, S. Ujfalusi, Á. Diószegi, et al. (+6)
146 [GO] 2022―Jun―24 PB2264: A REVIEW OF MORPHOLOGICAL ABNORMALITIES ON PERIPHERAL BLOOD FILM: BEYOND ROUTINE ANALYSIS IN THE COVID-19 POPULATION IN THE FIRST WAVE OF THE DISEASE. H. Fernandez Leyva
147 [GO] 2022―Jun―24 PB2292: AMSAN VARIANT OF GUILLAIN BARRE SYNDROME COMPLICATING THE RECOVERY PHASE OF COVID-19 RELATED DISEASE A. M. Haidary, S. Noor
148 [GO] 2022―Jun―24 PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS. K. Sychevskaya, S. Kravchenko, F. Babaeva, A. Misyurina, A. Korneeva, A. Abdulpatahov, et al. (+10)
149 [GO] 2022―Jun―24 PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS I. Tytorenko, I. Kryachоk, O. Alexik, T. Kadnikova, A. Martynchik, O. Novosad, et al. (+4)
150 [GO] 2022―Jun―24 P1675: POST-HOSPITAL DISCHARGE EVALUATION OF COVID-19 SURVIVORS WHO SUFFERED ACUTE VENOUS THROMBOEMBOLISM (VTE) DURING HOSPITALIZATION: THE BERGAMO EXPERIENCE C. Ambaglio, S. V. Benatti, C. J. Tartari, C. Giaccherini, L. Russo, M. Marchetti, et al. (+6)
151 [GO] 2022―Jun―24 PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION C. Varelas, E. Gavriilaki, I. Sakellari, P. Klonizakis, E.-E. Koravou, I. Christodoulou, et al. (+8)
152 [GO] 2022―Jun―24 PB1872: ANTIBODY RESPONSES AFTER COVID-19 VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA, EITHER TREATED OR NAÏVE. A MONOCENTRIC EXPERIENCE. I. Innocenti, G. Benintende, L. Stirparo, A. Tomasso, A. Mosca, A. Fresa, et al. (+3)
153 [GO] 2022―Jun―24 P1524: EFFECTS OF CORONAVIRUS DISEASE 2019 (COVID-19) VACCINATION ON HEMOGLOBIN LEVELS IN THALASSEMIA PATIENTS R. Vanavanitkun, P. Watanaboonyongcharoen, N. Uaprasert
154 [GO] 2022―Jun―24 PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA A. Hajizadeh Barfejani, S. Prasad, D. Henry
155 [GO] 2022―Jun―24 P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL T. Thomopoulos, A. Bouchla, A. Antoniadou, E. Terpos, M. Politou, K. Stamoulis, et al. (+16)
156 [GO] 2022―Jun―24 P1712: CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS Z. Güven, M. Keklik, A. Ünal
157 [GO] 2022―Jun―24 PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATOLOGICAL PATIENTS WITH 4 GRADE NEUTROPENIA AND CONCOMITANT CORONAVIRUS INFECTION K. Kaluzskaya, Y. Polyakov, E. Baryakh, E. Gemdzhian, E. Misyurina, E. Zhelnova, et al. (+3)
158 [GO] 2022―Jun―24 PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS. E. Baryakh, E. Misyurina, E. Zhelnova, K. Yatskov, O. Kochneva, Y. Polyakov, et al. (+6)
159 [GO] 2022―Jun―24 PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICAL PATIENTS IN THE POST-TRANSPLANT PERIOD E. Grishina, D. Gagloeva, E. Zhelnova, E. Karimova, E. Zotina, E. Paramonova, et al. (+2)
160 [GO] 2022―Jun―24 PB2198: EFFECTS OF NOVEL CORONAVIRUS VACCINATION ON THE COLLECTION OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS FROM HEALTHY DONORS Z. Wang, S. Cui, J. Xu, X. Tan, Y. Tian, X. Tang, Y. Wang
161 [GO] 2022―Jun―24 P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2. B. Shaw, J. Shortt, B. Rogers, Z. Kaplan, M. Low, G. Gregory, et al. (+5)
162 [GO] 2022―Jun―24 PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT M. Karimi, T. Zarei, S. Haghpanah, A. Azarkeivan, M. Naderi, S. Matin, et al. (+5)
163 [GO] 2022―Jun―24 P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES L. S. Boerenkamp, C. R. Pothast, R. C. Dijkland, I. H. van Loo, L. Wieten, C. J. Halkes, et al. (+2)
164 [GO] 2022―Jun―24 P1680: INFLUENCE OF D-DIMERS ON THROMBOEMBOLIC RISK IN PATIENTS WITH SARS-COV-2 IN AN INTENSIVE CARE UNIT A. Coelho, P. Moura, I. Santos, P. Martins, J. Carda, A. B. Sarmento-Ribeiro
165 [GO] 2022―Jun―24 P1588: A SINGLE CENTER COMPARATIVE CLINICAL ANALYSIS OF THE SARS-COV-2 INFECTION BEFORE AND AFTER VACCINATION IN PATIENTS DIAGNOSED WITH HEMATOLOGIC MALIGNANCIES M. Jiménez, S. Novoa, C. Fernandez-Naval, V. Navarro, C. Andrés, M. Martínez-Gallo, et al. (+22)
166 [GO] 2022―Jun―24 P1605: OUTCOME OF SARS-COV-2 INFECTION IN HAEMATOLOGICAL CANCER PATIENTS (PTS) IN TWO DIFFERENT PANDEMIC PHASES AT A SINGLE CENTRE R. Rodrigues, A. C. Freitas, S. Esteves, M. Gomes da Silva
167 [GO] 2022―Jun―24 PB2268: IMPACT OF HEMATOLOGICAL DISORDERS ON MORTALITY AND SERIOUS OUTCOMES IN SARS-COV-2 INFECTION: A MULTICENTER COHORT STUDY A. P. Hernandez Perez, E. I. Apodaca-Chavez, I. A. Borjon-Cabada, R. E. Leon-Cantu, Y. S. Baltodano-Martinez, K. L. Osorno-Rodríguez, et al. (+6)
168 [GO] 2022―Jun―24 P1613: SINGLE-CELL ANALYSIS FOLLOWING SARS-COV-2 MRNA VACCINE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS E. Tranter, B. Obermayer-Wasserscheid, M.-L. Hütter-Krönke, C. Junkuhn, I.-W. Blau, G. L. Vuong, et al. (+2)
169 [GO] 2022―Jun―24 P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES L.-E. Tamariz-Amador, A. M. Battaglia, C. Maia, A. Zherniakova, C. Guerrero, A. Zabaleta, et al. (+19)
170 [GO] 2022―Jun―24 PB2257: SARS-COV-2 VARIANTS DETECTED IN EMPLOYEES OF ONE MEDICAL CENTER B. Biderman, O. Gavrilina, O. Glinstchikova, T. Makarik, I. Fevraleva, D. Tikhomirov, et al. (+2)
171 [GO] 2022―Jun―24 PB2279: REDUCED ABSOLUTE COUNT OF MONOCYTES IN PATIENTS CARRYING HEMATOLOGICAL NEOPLASMS AND SARS-COV2 BREAKTHROUGH INFECTION A. Romano, C. Conticello, S. Filetti, A. Bulla, A. Chiarenza, V. Del Fabro, et al. (+7)
172 [GO] 2022―Jun―24 P1598: SARS-COV2 INFECTION IN FULLY VACCINATED PATIENTS WITH LYMPHOID MALIGNANCIES DURING THE “THIRD WAVE”: A SINGLE-CENTER EXPERIENCE OF 57 PATIENTS. V. Strafella, T. Perrone, P. Masciopinto, A. Giordano, F. Gaudio, M. C. Longo, et al. (+9)
173 [GO] 2022―Jun―24 PB2270: CLEARANCE OF PERSISTENT SARS-COV2 INFECTION WITH ANTIBODY CONTAINING PLASMA IN LEUKEMIA AND LYMPHOMA PATIENTS M. Janssen, A. Leo, C. Wolf, R. Bartenschlager, A. Schmitt, I. Haberbosch, et al. (+9)
174 [GO] 2022―Jun―24 PB2269: HUMORAL AND T-CELL RESPONSES TO SARS-COV2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA MANAGED IN THE COMMUNITY SETTING H. Holik, I. Krečak, I. Vučinić Ljubičić, L. Cvetko Krajinović, A. Požgain, I. Čabraja, et al. (+4)
175 [GO] 2022―Jun―24 P1711: LOCKDOWNS AND CANCER DIAGNOSIS: IMPACT OF COVID19 PANDEMIC ON NEW HAEM-ONC PRESENTATIONS D. Discalicau, P. Greaves
176 [GO] 2022―Jun―23 S283: ERN-EUROBLOODNET EUROPEAN REGISTRY OF PATIENTS AFFECTED BY RED BLOOD CELL DISORDERS AND COVID-19 P. Velasco, F. Longo, A. Piolatto, E. J. Bardón-Cancho, B. Ponce-Salas, P. Flevari, et al. (+44)
177 [GO] 2022―Jun―23 P363: TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVID-19 E. Paramonova, E. Zhelnova, E. Misyurina, E. Baryakh, E. Karimova, E. Zotina, et al. (+3)
178 [GO] 2022―Jun―23 P643: RISK FACTORS FOR UNFAVORABLE OUTCOME OF HOSPITALIZED PANTIENTS WITH CONCURENT CHRONIC LYMPHOCYTIC LEUKEMIA AND COVID-19 - EXPERIENCE OF THREE SERBIAN UNIVERSITY CENTERS Z. Cvetkovic, O. Markovic, K. Markovic, A. Novkovic, A. Divac, N. Vukosavljevic, et al. (+2)
179 [GO] 2022―Jun―23 P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB F. Palandri, D. Bartoletti, E. M. Elli, G. Auteri, M. Bonifacio, G. Benevolo, et al. (+37)
180 [GO] 2022―Jun―23 P1330: IMPACT OF COVID-19 IN HSCT ACTIVITY. A SURVEY FROM THE INFECTIOUS DISEASES WORKING PARTY (IDWP) OF EBMT R. De La Camara, Z. Szmit, P. Ljungman, N. Knelange, L. Wendel, G. Tridello, K. Kalwak
181 [GO] 2022―Jun―23 P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS S. Saußele, N. Evans, F. E. Nicolini, E. Chelysheva, D. Réa, F. Castagnetti, et al. (+4)
182 [GO] 2022―Jun―23 S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION C. Müller-Tidow, M. Janssen, U. Schäkel, J. Gall, A. Leo, P. Stelmach, et al. (+43)
183 [GO] 2022―Jun―23 P1066: OUTCOMES OF COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS - AN OBSERVATIONAL COHORT STUDY FROM A LARGE ACADEMIC CANCER CENTER IN THE UNITED STATES S. Venugopal, H. Song, C. Young, M. A. Cutherell, J. A. Baganz, S. Zatorsky, et al. (+8)
184 [GO] 2022―Jun―23 P1357: IMPAIRED CELLULAR RESPONSES AGAINST SARS-COV-2 AFTER COVID-19 INFECTION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A.-C. Mamez, A. Pradier, C. Stephan, F. Giannotti, S. Masouridi-Levrat, S. Morin, et al. (+9)
185 [GO] 2022―Jun―23 P658: COMPARISON OF CHARACTERISTICS AND OUTCOME OF COVID-19 INFECTION IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE AND IN PATIENTS FROM THE GENERAL POPULATION - EXPERIENCE FROM THREE UNIVERSITY CENTERS O. Markovic, A. Divac, Z. Cvetkovic, D. Stanisavljevic, K. Markovic, I. Bukurecki, et al. (+4)
186 [GO] 2022―Jun―23 P1358: WILL COVID-19 PANDEMIC CHANGE MOBILIZATION STRATEGY OF HEMATOPOIETIC STEM CELLS IN MULTIPLE MYELOMA PATIENTS FOR THE BETTER? B. Marques, A. Roque, L. Ruzickova, J. P. Carda, M. Gomes, A. B. Sarmento Ribeiro, C. Geraldes
187 [GO] 2022―Jun―23 P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES D. Galusic, S. Basic - Kinda, A. Pijuk, V. Milunovic, B. Dreta, N. Franjic, et al. (+6)
188 [GO] 2022―Jun―23 S244: EFFECT OF ANTI-SPIKE NEUTRALIZING MONOCLONAL ANTIBODIES ON COVID-19 PROGRESSION AND TIME TO VIRAL CLEARANCE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND SARS-COV-2 INFECTION: THE GIMEMA EXPERIENCE V. Marasco, A. Guidetti, A. Piciocchi, A. Candoni, M. Bocchia, R. Bruna, et al. (+9)
189 [GO] 2022―Jun―23 P559: HUMORAL RESPONSE TO MRNA-BASED COVID-19 VACCINE IN PATIENTS WITH MYELOID MALIGNANCIES A. Mori, M. Onozawa, S. Tsukamoto, T. Ishio, E. Yokoyama, K. Izumiyama, et al. (+5)
190 [GO] 2022―Jun―23 S284: RISK FACTORS AND OUTCOMES OF PATIENTS WITH HAEMATOLOGICAL MALIGNANCY AND COVID-19: ONGOING REDUCTION IN MORTALITY DURING THE 3RD WAVE OF THE PANDEMIC J. Maddox
191 [GO] 2022―Jun―23 P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS P. Harrington, J. Saunders, C. Saha, A. Sheikh, R. Dillon, K. Raj, et al. (+14)
192 [GO] 2022―Jun―23 S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) M. S. Infante, J. Salmanton-García, A. Fernandez-Cruz, F. Marchesi, Z. RÁČIL, M. Hanakova, et al. (+25)
193 [GO] 2022―Jun―23 P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) N. Sgherza, P. Curci, R. Rizzi, D. Roccotelli, M. Croce, M. Avantaggiato, et al. (+5)
194 [GO] 2022―Jun―23 P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT P. Storti, V. Marchica, R. Vescovini, V. Franceschi, L. Russo, V. Raimondi, et al. (+8)
195 [GO] 2022―Jun―23 P832: CLINICAL OUTCOMES AND IMMUNE RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA R. Rajput, X. Ma, K. L. Boswell, M. Gaudinski, E. M. Groarke, J. Lotter, et al. (+6)
196 [GO] 2022―Jun―23 P660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER STUDY. F. R. Mauro, D. Giannarelli, C. Galluzzo, A. Visentin, A. M. Frustaci, P. Sportoletti, et al. (+18)
197 [GO] 2022―Jun―23 P1098: OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN MAINTENANCE TREATMENT WITH ANTICD20 MONOCLONAL ANTIBODIES IN SARS-COV2 ERA: RESULTS FROM A MULTICENTER, RETROSPECTIVE- PROSPECTIVE ITALIAN STUDY. A. Castellino, C. Castellino, C. Boccomini, M. Clerico, P. Nicoli, A. Vanazzi, et al. (+24)
198 [GO] 2022―Jun―23 S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS OF EPICOVIDEHA SURVEY M. Marchetti, J. Salmanton-García, S. El-Ashwah, M. V. Sacchi, F. Marchesi, Z. Ráčil, et al. (+21)
199 [GO] 2022―Jun―21 Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Aimilia D. Sklirou, Maria Gavriatopoulou, Harry Alexopoulos, Panagiotis Malandrakis, et al. (+3)
200 [GO] 2022―May―12 Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
201 [GO] 2022―Apr―08 Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry Marie-Kristin Tilch, Carlo Visco, Sandra Kinda, Olivier Hermine, Milena Kohn, Caroline Besson, et al. (+11)
202 [GO] 2022―Apr―06 COVID-19 AND MYELOMA H Ludwig, P Sonneveld, M Boccadoro, E Terpos
203 [GO] 2022―Apr―06 P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE ON 110 PATIENTS Guldane Cengiz Seval, Ekin Kircali, Derya Koyun, Bulent Karakaya, Hulya Yilmaz, Gul Yavuz, et al. (+7)
204 [GO] 2022―Apr―06 B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA E Terpos, M Gavriatopoulou, I Ntanasis-Stathopoulos, A Briasoulis, S Gumeni, P Malandrakis, et al. (+6)
205 [GO] 2022―Apr―06 P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) N Sgherza, R Rizzi, P Curci, D Roccotelli, M Croce, M Avantaggiato, et al. (+2)
206 [GO] 2022―Feb―15 Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis Nora Liebers, Stefan O. Schönland, Claudius Speer, Dominic Edelmann, Paul Schnitzler, Hans-Georg Kräusslich, et al. (+3)
207 [GO] 2022―Feb―15 Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies Verena Petzer, Normann Steiner, Olga Angelova-Unterberger, Gabriele Hetzenauer, Kathrin Philipp-Abbrederis, Ella Willenbacher, et al. (+16)
208 [GO] 2022―Feb―01 P130: PROVIDING ADEQUATE HEALTHCARE TO PEOPLE WITH HEMOGLOBINOPATHIES DURING THE PANDEMIC (COVID-19) S Sophia Delicou, A Aikaterini Xydaki, K Konstantinos Manganas, L Lucia Evliati, C Chrysoula Kalkana, M Michael Diamantidis, et al. (+4)
209 [GO] 2022―Jan―31 P111: COVID-19 IN PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE: A SINGLE CENTER EXPERIENCE M Dimopoulou, V Komninaka, P Flevari, V Bartzi, K Repa, E Voskaridou
210 [GO] 2022―Jan―31 P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS H Malhan, B Iqbal, Y Ghazwani, A AlHakim, S Ali, H Omar, et al. (+7)
211 [GO] 2022―Jan―31 P131: REAL-TIME VACCINATION IMPACTS IN SICKLE CELL DISEASE: A REAL-WORLD PATIENT CASE STUDY FOR INFLUENZA AND COVID-19 VACCINATION O Agrippa, K Summers, K Anie, P Telfer, J James, E Low
212 [GO] 2022―Jan―31 S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS P Delaporta, D Kyriakopoulou, N Ioakeimidou, E Solomou, I Binenbaum, K Toutoudaki, et al. (+3)
213 [GO] 2022―Jan―31 P116: THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER M Maria Vousvouki, A Aikaterini Teli, A Alkistis Adramerina, S Stamatia Theodoridou, M Marina Economou
214 [GO] 2021―Dec―22 “Long COVID-19” of Researchers: What to Do Next? Eleni Gavriilaki, Alba Maiques-Diaz
215 [GO] 2021―Dec―17 Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals Evangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, Filia Apostolakou, Sentiljana Gumeni, Maria Gavriatopoulou, et al. (+8)
216 [GO] 2021―Nov―12 Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia Colin Vercueil, Lauriane Eberst, Catherine Humbrecht, Luc-Matthieu Fornecker
217 [GO] 2021―Oct―27 Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review David Klank, Martin Hoffmann, Bernd Claus, Florian Zinke, Raoul Bergner, Peter Paschka
218 [GO] 2021―Oct―14 A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination Priya Sriskandarajah, Jess Hobart, Deepti H. Radia, Andrew F. Whyte
219 [GO] 2021―Jul―13 Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine Marie-Estelle Gaignard, Sven Lieberherr, Andreas Schoenenberger, Rudolf Benz
220 [GO] 2021―Jul―13 Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis Efstathios Kastritis, Evangelos Terpos, Aimilia Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni-Dimitra Papanagnou, et al. (+5)
221 [GO] 2021―Jun―29 COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma Erik Gaitzsch, Verena Passerini, Elham Khatamzas, Carolin D. Strobl, Maximilian Muenchhoff, Clemens Scherer, et al. (+33)
222 [GO] 2021―Jun―25 EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19 Jon Salmanton-García, Alessandro Busca, Oliver A. Cornely, Paolo Corradini, Martin Hoenigl, Nikolai Klimko, et al. (+5)
223 [GO] 2021―Jun―25 Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021 Jamie Saunders, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O’Sullivan, Claire Woodley, Susan Asirvatham, et al. (+11)
224 [GO] 2021―Jun―14 COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment Michele Clerico, Irene Dogliotti, Andrea Calcagno, Daniele Grimaldi, Sarah Leone, Simone Ragaini, et al. (+10)
225 [GO] 2021―Jun―04 Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19 Marcel Levi
226 [GO] 2021―Feb―26 SARS-CoV-2 Vaccines in Patients With Multiple Myeloma Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, Evangelos Terpos, Meletios A. Dimopoulos
227 [GO] 2021―Feb―24 Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study Isabel Regalado-Artamendi, Ana Jiménez-Ubieto, José Ángel Hernández-Rivas, Belén Navarro, Lucía Núñez, Concha Alaez, et al. (+18)
228 [GO] 2021―Jan―27 EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic Martin Dreyling, Igor Aurer, Massimo Federico, Mats Jerkeman, Marie Jose Kersten, Kim Linton, et al. (+3)
229 [GO] 2020―Dec―29 DOAC in COVID-19: Yes or No? Roger E. Schutgens
230 [GO] 2020―Nov―25 Effect of the COVID-19 Pandemic on Laboratory and Clinical Research: A Testimony and a Call to Action From Researchers Anna Kabanova, Eleni Gavriilaki, Benedikt W. Pelzer, Lorenzo Brunetti, Alba Maiques-Diaz
231 [GO] 2020―Nov―10 Hypoferremia is Associated With Increased Hospitalization and Oxygen Demand in COVID-19 Patients Theresa Hippchen, Sandro Altamura, Martina U. Muckenthaler, Uta Merle
232 [GO] 2020―Oct―01 Immune Thrombocytopenia in a Patient Recovering From COVID-19 Symeon Metallidis, Georgia Gioula, Maria Papaioannou, Maria Exindari, Theofilos Chrysanthidis, Olga Tsachouridou, et al. (+5)
233 [GO] 2020―Sep―24 SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience Sandra Mossuto, Enrico Attardi, Francesco Alesiani, Emanuele Angelucci, Enrico Balleari, Massimo Bernardi, et al. (+47)
234 [GO] 2020―Sep―18 D-dimer in COVID-19: A Guide With Pitfalls Roger E. Schutgens
235 [GO] 2020―Sep―17 Correction Notice: Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threatening Features Within the Early Post-engraftment Phase
236 [GO] 2020―Sep―12 COVID-19 - Impact on Childhood Haematology Patients Tom F.W. Wolfs, Andishe Attarbaschi, Adriana Balduzzi, Maria Ester Bernardo, Simon Bomken, Arndt Borkhardt, et al. (+10)
237 [GO] 2020―Sep―02 SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma Chiara Rusconi, Giulio Cassanello, Anna Guidetti, Chiara Oltolini, Vincenzo Marasco, Lucio Morabito, et al. (+5)
238 [GO] 2020―Aug―11 Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19 Erik Hameister, Sebastian M. Stolz, Yvonne Fuhrer, Friedrich Thienemann, Dominik J. Schaer, Johannes Nemeth, et al. (+11)
239 [GO] 2020―Aug―11 Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase Chiara Oltolini, Anna Guidetti, Marco Ripa, Barbara Castiglioni, Chiara Tassan Din, Sara Mastaglio, et al. (+12)
240 [GO] 2020―Aug―11 A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy Nuray Kusadasi, Maaike Sikma, Albert Huisman, Jan Westerink, Coen Maas, Roger Schutgens
241 [GO] 2020―Jul―31 Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic Dipti Talaulikar, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos, Shirley D'Sa, et al. (+12)
242 [GO] 2020―Jul―31 How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, et al. (+5)
243 [GO] 2020―Jul―08 The Emerging Role of Convalescent Plasma in the Treatment of COVID-19 Theodora Psaltopoulou, Theodoros N. Sergentanis, Vasiliki Pappa, Marianna Politou, Evangelos Terpos, Sotirios Tsiodras, et al. (+2)
244 [GO] 2020―Jun―04 Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections Paolo Corradini, Giorgia Gobbi, Filippo de Braud, Jessica Rosa, Chiara Rusconi, Giovanni Apolone, Cristiana Carniti
 [1] 

244 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.039 sec